Testing effectiveness (Phase 2)Study completedNCT01364662
What this trial is testing
Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Who this might be right for
Impulsive Aggression Comorbid With ADHD
Supernus Pharmaceuticals, Inc. 121